Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

K+ channels as targets for specific immunomodulation.

K George Chandy1, Heike Wulff, Christine Beeton

  • 1Department of Physiology and Biophysics, University of California, Irvine, CA 92697, USA. gchandy@uci.edu

Trends in Pharmacological Sciences
|May 4, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitochondria-Targeting Moieties Based on N-Tethered Pyridinium Cations.

Angewandte Chemie (International ed. in English)·2026
Same author

Macrophage-Fibroblast Crosstalk Shapes Wound Repair Signaling In Vitro.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2026
Same author

Translating Science into Practice Using University-State Government Partnerships: The EPIS Model.

Prevention science : the official journal of the Society for Prevention Research·2026
Same author

Structural basis for the subtype-selective activation of K<sub>Ca</sub>3.1 channels.

Structure (London, England : 1993)·2026
Same author

Kv1.3 as an upstream regulator of oxidative stress-mediated neuroinflammation following organic dust exposure in murine <i>in vitro</i>, <i>ex vivo</i>, and <i>in vivo</i> models.

Frontiers in toxicology·2026
Same author

Targeting synovial fibroblast KCa1.1 channels in rheumatoid arthritis.

Current opinion in immunology·2026

Selective potassium channel blockers targeting Kv1.3 and IKCa1 channels show therapeutic promise for immune disorders. Their distinct expression patterns in T cells change with activation and differentiation, offering specific immunomodulatory strategies.

Area of Science:

  • Immunology
  • Cellular Physiology
  • Pharmacology

Background:

  • Kv1.3 and IKCa1 K(+) channels are expressed in T cells.
  • Channel expression varies with lymphocyte activation and differentiation state.

Purpose of the Study:

  • Review functional roles of Kv1.3 and IKCa1 channels in naïve and memory T cells.
  • Describe development of selective Kv1.3 and IKCa1 channel inhibitors.
  • Provide rationale for therapeutic use of these inhibitors in immunological disorders.

Main Methods:

  • Literature review of T cell channel expression and function.
  • Analysis of selective K(+) channel blocker development.
  • Synthesis of data for therapeutic rationale.

Main Results:

Related Experiment Videos

  • Distinct expression patterns of Kv1.3 and IKCa1 channels in T cells.
  • Changes in channel phenotype during T cell activation and differentiation.
  • Development of selective inhibitors for Kv1.3 and IKCa1 channels.

Conclusions:

  • Kv1.3 and IKCa1 channels represent promising targets for immunomodulation.
  • Selective K(+) channel blockers offer potential therapeutic strategies for immunological disorders.